Deep search
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
FDA, Cymbalta and antidepressant duloxetine
Duloxetine antidepressant recalled over presence of toxic chemical
Some bottles of the antidepressant duloxetine, sold under the brand name Cymbalta, were recalled due to the presence of a toxic chemical.
FDA Has Recalled Thousands of Bottles of Antidepressant Duloxetine, Sold Under Brand Name Cymbalta: Here’s Why
The Duloxetine Delayed-Release Capsules' voluntary recall began on Oct. 10 after the FDA deemed the medication the second-highest risk classification. Over 7,100 bottles of Duloxetine were recalled, including 500 delayed-release 20mg capsules. The lot number is 220128, and the expiration date is 12/2024, per the FDA report.
Thousands of bottles of common antidepressant Cymbalta recalled by FDA over cancer-causing chemical
Thousands of bottles of a commonly prescribed antidepressant drug were recalled because they contained a suspected cancer-causing chemical.
Antidepressants recalled over cancer-causing chemical; should you stop taking your pills?
The FDA recalled thousands of bottles of antidepressants after finding high levels of potentially cancer-causing chemicals. Here's what to look for.
7,100 bottles of antidepressant recalled by FDA now in 2nd highest risk class
Duloxetine Delayed-Release Capsules were recalled because the pills may contain high levels of a cancer-causing chemical.
Antidepressant recalled: 2nd-highest FDA risk level; drug contains cancerous chemical
The U.S. Food and Drug Administration updated the risk level of a recalled antidepressant due to the product containing high levels of a cancer-causing chemical.
FDA issues recall for antidepressant drug
The Federal Drug Administration issued a recall on Tuesday for a common medicine for depression. Over 7,000 bottles of Duloxetine were recalled due to the elevated presence of Nitrosamine, an ingredient believed to be cancerous,
Antidepressant recall: FDA upgrades risk level due to cancer-causing chemical
Now, the FDA is assigning the second-highest risk level to the recall of Duloxetine Delayed-Release Capsules, produced by Towa Pharmaceutical Europe, according to agency records and reported by SILive.com sister site NJ.com. Duloxetine is used to treat depression, anxiety and nerve pain caused by fibromyalgia.
Antidepressant recall: FDA upgrades medication risk class to 2nd highest level in recall update
The U.S. Food and Drug Administration is urging patients not to stop taking their prescribed medication if it falls under the recall but instead to address any concerns and other potential treatment o
FDA Recalls Thousands Of Duloxetine Antidepressant Bottles | Here's Why
The US Food and Drug Administration has recalled thousands of bottles of Duloxetine antidepressant, saying it contained high levels of a cancer-causing chemical. The federal agency has reportedly upgraded the level of risk.
Hosted on MSN
37m
Over 7,100 bottles of prescription antidepressants recalled over potentially cancer-causing substance
A pharmaceutical company issued a recall this month for thousands of bottles of duloxetine, a medicine often prescribed to ...
6h
This antidepressant is being recalled: Here’s why
The U.S. Food and Drug Administration (FDA) has issued a nationwide recall of thousands of bottles of antidepressants. These ...
WGAU Athens Radio on MSN
2h
FDA issues Cymbalta recall
More than 7,100 bottles of Cymbalta is being pulled by the FDA after the toxic chemical was discovered. In addition to treat ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Trending now
NK troops in RU confirmed
Linked to E. coli outbreak
Arlington visit records order
Trespassing charge upheld
Veteran film producer dies
2 US troops injured in raid
Kristy now Category 2
MO court upholds release
Dodgers legend dies
Lake Erie toxic algae study
To close 150 locations
First father-son duo in NBA
US fines American Airlines
Shooting trial delayed
Funds corruption guilty plea
FDA approves RSV vaccine
DOJ alleges racial bias
Giant ‘ghost’ fish spotted
GA election rules appeal
To appear on Rogan podcast
FAA finalizes safety rules
SK mulls arms for Ukraine
Brain stimulation study
Raises US growth forecast
Same-day pharmacy delivery
2025 Medicare changes
Six indicted for fraud in Ohio
US semiconductor tax credit
Hospitals' IV fluid shortage
Ordered to hand over assets
Reveals 2025 tax brackets
Related topics
Cymbalta
Food and Drug Administration
Feedback